From: Impact of skeletal muscle mass on postoperative complications in oral cancer surgery
Variable | Non-SSI (n = 75) | SSI (n = 45) | p-value |
---|---|---|---|
Age (years), median (range) | 63 (23–86) | 64 (20–80) | 0.39a |
Sex | |||
Male | 58 (77.3%) | 27 (60.0%) | 0.06b |
Female | 17 (22.3%) | 18 (40.0%) | |
SMI (cm2/m2), mean ± SD | 48.8 ± 7.4 | 44.2 ± 8.6 | 0.002a |
Low SMI | 7 (9.3%) | 13 (28.9%) | 0.001b |
BMI (kg/m2), mean ± SD | 23.0 ± 4.1 | 21.3 ± 3.6 | 0.020a |
Low BMI < 18.5 | 10 (13.3%) | 7 (15.5%) | 0.793b |
Stage | |||
II, III | 25 (33.3%) | 10 (22.2%) | 0.667b |
IV | 55 (73.3%) | 35 (77.8%) | |
Alcohol | 30 (40%) | 28 (62.2%) | 0.855b |
Smoking | 36 (48%) | 24 (44.4%) | 0.855b |
Location | |||
Tongue | 47 (62.7%) | 22 (48.9%) | 0.328b |
Mandible | 13 (17.3%) | 13 (28.9%) | |
Buccal mucosa | 5 (6.7%) | 5 (11.1%) | |
Floor of mouth | 10 (13.3%) | 5 (11.1%) | |
Neck dissection | |||
Unilateral | 64 (85.3%) | 36 (80.0%) | 0.459b |
Bilateral | 11 (14.7%) | 9 (20.0%) | |
ASA-PS score ≧ 2 | 27 (45.8%) | 23 (35.4%) | 0.274b |
ACE-27 | |||
0–1 | 30 (40.0%) | 13 (28.9%) | 0.244b |
2–3 | 45 (60.0%) | 32 (71.1%) | |
Preoperative laboratory data, median (IQR) | |||
Leukocyte count (× 109/l) | 6.2 (5.3–8.2) | 6.2 (4.9–6.8) | 0.205a |
Platelet count (× 109/l) | 23.3 (20.1–27.6) | 24.2 (20.6–28.2) | 0.591a |
Hemoglobin (g/dl) | 14.5 (14.1–14.8) | 14.3 (13.9–14.7) | 0.100a |
Albumin (g/dl) | 4.4 (4.1–4.7) | 4.4 (4.1–5.3) | 0.746a |
Prognostic nutritional index | 52.1 (49.0–55.8) | 52.0 (48.4–54.5) | 0.408a |
Operation time (min), median (IQR) | 783 (688–873) | 812 (668–857) | 0.816a |
Blood loss (ml), median (IQR) | 670 (420–1027) | 670 (450–950) | 0.924a |